X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Piramal Healthcare - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs PIRAMAL ENTERPRISES - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS PIRAMAL ENTERPRISES J.B.CHEMICALS/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 14.2 37.5 37.9% View Chart
P/BV x 2.2 3.7 60.2% View Chart
Dividend Yield % 0.2 0.7 26.5%  

Financials

 J.B.CHEMICALS   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
PIRAMAL ENTERPRISES
Mar-16
J.B.CHEMICALS/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs3181,065 29.9%   
Low Rs200805 24.8%   
Sales per share (Unadj.) Rs148.0383.0 38.6%  
Earnings per share (Unadj.) Rs19.155.1 34.6%  
Cash flow per share (Unadj.) Rs23.974.1 32.3%  
Dividends per share (Unadj.) Rs0.5017.50 2.9%  
Dividend yield (eoy) %0.21.9 10.3%  
Book value per share (Unadj.) Rs128.9719.9 17.9%  
Shares outstanding (eoy) m84.82172.56 49.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.72.4 71.6%   
Avg P/E ratio x13.617.0 79.9%  
P/CF ratio (eoy) x10.812.6 85.6%  
Price / Book Value ratio x2.01.3 154.5%  
Dividend payout %2.631.8 8.2%   
Avg Mkt Cap Rs m21,951161,344 13.6%   
No. of employees `0002.73.8 72.3%   
Total wages/salary Rs m1,84116,898 10.9%   
Avg. sales/employee Rs Th4,590.917,472.6 26.3%   
Avg. wages/employee Rs Th673.44,466.9 15.1%   
Avg. net profit/employee Rs Th592.12,512.8 23.6%   
INCOME DATA
Net Sales Rs m12,55166,099 19.0%  
Other income Rs m5422,425 22.3%   
Total revenues Rs m13,09368,524 19.1%   
Gross profit Rs m2,05518,723 11.0%  
Depreciation Rs m4123,274 12.6%   
Interest Rs m969,388 1.0%   
Profit before tax Rs m2,0888,485 24.6%   
Minority Interest Rs m03 -12.1%   
Prior Period Items Rs m01,593 0.0%   
Extraordinary Inc (Exp) Rs m0457 0.0%   
Tax Rs m4691,032 45.5%   
Profit after tax Rs m1,6199,506 17.0%  
Gross profit margin %16.428.3 57.8%  
Effective tax rate %22.512.2 184.7%   
Net profit margin %12.914.4 89.7%  
BALANCE SHEET DATA
Current assets Rs m7,77847,488 16.4%   
Current liabilities Rs m4,358104,362 4.2%   
Net working cap to sales %27.2-86.0 -31.7%  
Current ratio x1.80.5 392.2%  
Inventory Days Days5541 134.6%  
Debtors Days Days8051 156.5%  
Net fixed assets Rs m5,71326,532 21.5%   
Share capital Rs m170345 49.1%   
"Free" reserves Rs m10,547114,024 9.2%   
Net worth Rs m10,937124,221 8.8%   
Long term debt Rs m075,812 0.0%   
Total assets Rs m15,574308,356 5.1%  
Interest coverage x22.81.9 1,198.6%   
Debt to equity ratio x00.6 0.0%  
Sales to assets ratio x0.80.2 376.0%   
Return on assets %11.06.1 179.7%  
Return on equity %14.87.7 193.4%  
Return on capital %20.010.0 200.4%  
Exports to sales %48.717.2 283.4%   
Imports to sales %7.16.6 107.2%   
Exports (fob) Rs m6,11511,362 53.8%   
Imports (cif) Rs m8894,364 20.4%   
Fx inflow Rs m6,16914,435 42.7%   
Fx outflow Rs m1,2855,183 24.8%   
Net fx Rs m4,8849,253 52.8%   
CASH FLOW
From Operations Rs m1,397-67,773 -2.1%  
From Investments Rs m-320-8,768 3.7%  
From Financial Activity Rs m-1,19676,199 -1.6%  
Net Cashflow Rs m-102-342 29.9%  

Share Holding

Indian Promoters % 55.4 52.9 104.7%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 4.0 84.8%  
FIIs % 3.9 26.6 14.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 16.5 224.2%  
Shareholders   30,437 93,274 32.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   JUBILANT LIFE SCIENCES  DR. DATSONS LABS  GLENMARK PHARMA  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare J.B.CHEMICALS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Finish to the Week Post Vishal Sikka's Exit as CEO of Infosys(Closing)

Share markets in India witnessed selling pressure, led by slump in shares of Infosys Ltd. after Vishal Sikka resigned as chief executive officer of the country's second-largest software services exporter.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Aug 18, 2017 03:37 PM

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 5-YR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS